DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Cohance Lifesciences Limited — Press Release

NSE 1 hr ago·3 Sept 2026, 2:39 pm

Cohance Lifesciences

Cohance Lifesciences has informed stock exchanges about a press release issued on September 3, 2026. The company has not yet disclosed the specific content of this announcement to the public.

For investors, this development is currently limited to a procedural update. The lack of specific details means the immediate impact on the stock's valuation remains unclear. Investors should await the full text of the press release to understand the company's strategic direction or any material information.

Moving forward, market participants will focus on the key highlights of the press release. Monitoring the company's official filings and subsequent trading volumes will be essential to gauge the market's reaction to the news.